References
- Childs R, Chemoff A, Contentin N, et al. Regression of metastatic renal-cell carcinoma after nonmyeloablative allo-geneic peripheral-blood stem-cell transplantation. N Engl J Med 2000;343:750–758.
- Slavin S, Nagler A, Naparstek E, et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytor-eduction for the treatment of malignant and nonmalignant hematologic disease. Blood 1998;91:756–763.
- Slavin S, Or R, Aker M, et al. Nonmyeloablative stem cell transplantation for the treatment of cancer and life-threatening nonmalignant disorders: Past accomplishments and future goal. Cancer Chemother Pharmacol 2001;8\(suppl 1): S79—S84.
- Fujimaki K, Maruta A, Yoshida M, et al. Severe cardiac toxicity in hematological stem cell transplantation: Predictive value of reduced left ventricular ejection fraction. Bone Marrow Transplant 2001;27:307–310.
- McDonagh TA, Robb SD, Murdoch DP, et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet 1998;351:9–13.
- Muders F, Kromer EP, Griese DP, et al. Evaluation of plasma natriuretic peptides as markers for left ventricular dysfunction. Am Heart J 1997;134:442–450.
- Levin E, Gardner DG, Samson PD. Natriuretic peptides. N Eng J Med 1998;339:321–327.
- Mukoyama M, Nakao K, Saito Y, et al. Brain natriuretic peptide as a novel cardiac hormone: Evidence for an exqusive dual natriuretic peptide system, atrial natriuretic pedptide and brain natriuretic peptide. J Clin Invest 1991;87:1402–1412.
- Yoshimura M, Yasue H, Okumura K, et al. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation 1993;87:464–469.
- Gottlieb SS, Kukin MC, Ahern D, et al. Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure. J Am Coll Cardiol 1989;13:1534–1539.
- Omland T, Aakvaag A, Bonarjee VVS, et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction: Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation 1996;93:1963–1969.
- Arai H, Nakao K, Narito M, et al. Augmented expression of atrial natriuretic polyp eptid gene in ventricles of spontaneously hypertensive rats (SHR) and SHR-stroke prone. Circ Res 1988;62:926–930.
- Saito Y, Nakao K, Arai H, et al. Augmented secretion of atrial natriuretic polypeptide gene in ventricle of human failing heart. J Clin Invest 1995;44:S61—S64.
- Kohno M. Horio T, Yokokawa K, et at. Brain natriuretic peptide as a cardiac hormone in essential hypertension. Am J Med 1992;92:29–34.
- Nishikimi T, Yoshihara F, Morimoto A, et al. Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension. Hypertension 1996;28:22–30.
- Tsutamoto T, Wads A, Maeda K, at al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: Prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 1997;96:509–516.